Medican Enterprises(MDCN)
$0.000.00 (0.00%)
MDCN
Medican Enterprises financials statements
$0.00
At close:0.00 (0.00%)
Medican Enterprises (MDCN) Ratios
48 Followers
Medican Enterprises Ratios
MDCN's free cash flow for Q3 2022 was $4.46M. For the 2022 fiscal year, MDCN's free cash flow was increased by $0.00 and operating cash flow was $4.46M. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | 0.35 | 0.04 | 0.17 | 0.01 |
| Operating Cash Flow Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -19.74M | $ -25.07M | $ -27.85M | $ -34.43M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.41 | 0.58 | 0.69 | 0.84 |
| Debt-to-Equity Ratio | 0.70 | 1.41 | 2.21 | 5.10 |
| Debt-to-Capital Ratio | 0.41 | 0.58 | 0.69 | 0.84 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.58 | 0.69 | 0.84 |
| Financial Leverage Ratio | 1.70 | 2.41 | 3.21 | 6.10 |
| Debt Service Coverage Ratio | 84.75 | 4.31 | 9.57 | 6.88 |
| Interest Coverage Ratio | 8.86 | 1.55 | -0.18 | 3.39 |
| Debt to Market Cap | 5088.66 | 3264.36 | 27618.86 | 34123.26 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 2.79 | 21.10 | 5.41 | 101.08 |
| Profitability Margins | ||||
| Gross Profit Margin | 48.29% | 47.89% | 19.38% | 100.00% |
| EBIT Margin | 246.68% | 10.10% | 397.10% | 26.91% |
| EBITDA Margin | 270.83% | 28.03% | 465.94% | 54.58% |
| Operating Profit Margin | 28.31% | 10.10% | -8.81% | 26.91% |
| Pretax Profit Margin | 243.46% | 3.60% | 348.46% | 18.98% |
| Net Profit Margin | 243.46% | 3.60% | 348.46% | 18.98% |
| Continuous Operations Profit Margin | 243.46% | 3.60% | 348.46% | 18.98% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 859.93% | 35.65% | -3955.78% | 70.52% |
| Return on Assets (ROA) | 13.17% | 0.35% | 9.50% | 0.29% |
| Return on Equity (ROE) | 22.35% | 0.84% | 30.52% | 1.75% |
| Return on Capital Employed (ROCE) | 1.53% | 0.98% | -0.24% | 0.41% |
| Return on Invested Capital (ROIC) | 1.53% | 0.98% | -0.24% | 0.41% |
| Return on Tangible Assets | 13.17% | 0.35% | 9.50% | 0.29% |
| Earnings Yield | 163101.91% | 1959.85% | 381150.31% | 11732.83% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.12 | 0.24 | 0.07 | 0.07 |
| Asset Turnover | 0.05 | 0.10 | 0.03 | 0.02 |
| Working Capital Turnover Ratio | 11.99 | 22.03 | 55.20 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 1493319.00 | 303436.50 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 1493319.00 | 303436.50 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.30 | 0.05 | 0.49 | 0.01 |
| Operating Cash Flow to Sales Ratio | 2.29 | 0.29 | 12.42 | 0.47 |
| Free Cash Flow Yield | 153377.42% | 15582.83% | 1358843.16% | 28839.42% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | 0.00 | 0.05 | 0.00 | 0.01 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.01 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.01 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 2.79 | 21.11 | 5.41 | 101.08 |
| Enterprise Value | 19.75M | 25.07M | 27.85M | 34.43M |
| EV to EBITDA | 2.79 | 21.11 | 5.41 | 101.08 |
| EV to Sales | 7.57 | 5.92 | 25.23 | 55.17 |
| EV to Free Cash Flow | 3.31 | 20.66 | 2.03 | 118.27 |
| EV to Operating Cash Flow | 3.31 | 20.66 | 2.03 | 118.27 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 0.36 | 0.88 | 0.71 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.94 | 7.95 | 3.57 | 2.46 |
Currency in USD

